Cellosaurus TALL-1 [Human adult T-ALL] (CVCL_1736)

Cell line name TALL-1 [Human adult T-ALL]
Synonyms TALL1; T-ALL-1; T-ALL1; T-cell Acute Lymphoblastic Leukemia-1
Accession CVCL_1736
Resource Identification Initiative To cite this cell line use: TALL-1 [Human adult T-ALL] (RRID:CVCL_1736)
Comments Part of: Cancer Cell Line Encyclopedia (CCLE) project.
Doubling time: 73 hours (PubMed=305872); ~50-70 hours (DSMZ); ~2 days (JCRB).
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Deep exome analysis.
Omics: SNP array analysis.
Omics: Transcriptome analysis.
Derived from sampling site: Bone marrow.
Disease Adult T acute lymphoblastic leukemia (NCIt: C9142)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Category Cancer cell line
STR profile Source(s): Cosmic-CLP; DSMZ; JCRB; RCB; TKG

Markers:
AmelogeninX,Y (Cosmic-CLP; DSMZ; JCRB)
X (RCB; TKG)
CSF1PO11,13
D13S3178,9
D16S5399,10
D5S8189,12
D7S82010,11
TH017,9
TPOX8,11
vWA17,19
Publications

PubMed=197412; DOI=10.1038/267843a0
Miyoshi I., Hiraki S., Tsubota T., Kubonishi I., Matsuda Y., Nakayama T., Kishimoto H., Kimura I., Masuji H.
Human B cell, T cell and null cell leukaemic cell lines derived from acute lymphoblastic leukaemias.
Nature 267:843-844(1977)

PubMed=305872; DOI=10.20772/cancersci1959.69.1_115
Hiraki S., Miyoshi I., Kubonishi I., Matsuda Y., Nakayama T., Kishimoto H., Machida K., Masuji H., Kimura I.
Establishment of a T-cell line from human lymphosarcoma.
Gann 69:115-118(1978)

PubMed=6966589; DOI=10.20772/cancersci1959.71.1_155
Miyoshi I., Kubonishi I., Sumida M., Hiraki S., Tsubota T., Kimura I., Miyamoto K., Sato J.
A novel T-cell line derived from adult T-cell leukemia.
Gann 71:155-156(1980)

PubMed=9290701; DOI=10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D
Jia L.-Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T., Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M., Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.
Screening the p53 status of human cell lines using a yeast functional assay.
Mol. Carcinog. 19:243-253(1997)

PubMed=10071127; DOI=10.1016/S0145-2126(98)00146-5
Kawamura M., Ohnishi H., Guo S.X., Sheng X.M., Minegishi M., Hanada R., Horibe K., Hongo T., Kaneko Y., Bessho F., Yanagisawa M., Sekiya T., Hayashi Y.
Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.
Leuk. Res. 23:115-126(1999)

PubMed=16408098; DOI=10.1038/sj.leu.2404081
Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.
JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.
Leukemia 20:471-476(2006)

PubMed=22460905; DOI=10.1038/nature11003
Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.K., Yu J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L., Winckler W., Reich M., Li N., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Nature 483:603-607(2012)

PubMed=22675565; DOI=10.1371/journal.pone.0038463
Kalender Atak Z., De Keersmaecker K., Gianfelici V., Geerdens E., Vandepoel R., Pauwels D., Porcu M., Lahortiga I., Brys V., Dirks W.G., Quentmeier H., Cloos J., Cuppens H., Uyttebroeck A., Vandenberghe P., Cools J., Aerts S.
High accuracy mutation detection in leukemia on a selected panel of cancer genes.
PLoS ONE 7:E38463-E38463(2012)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

Cross-references
Cell line collections DSMZ; ACC-521
JCRB; JCRB0086
RCB; RCB2084
TKG; TKG 0251
Cell line databases/resources CCLE; TALL1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
Cosmic-CLP; 909762
GDSC; 909762
LINCS_LDP; LCL-1024
Ontologies BTO; BTO:0003739
CLO; CLO_0051547
Biological sample resources BioSample; SAMN03472057
BioSample; SAMN03473519
Chemistry resources ChEMBL-Cells; CHEMBL3308541
ChEMBL-Targets; CHEMBL2366254
Gene expression databases GEO; GSM887688
GEO; GSM888780
Polymorphism and mutation databases Cosmic; 909762
Cosmic; 1375581
Cosmic; 1641379
Cosmic; 1760534
Cosmic; 1760556
Cosmic; 2165721